Xiaolin Wu⁵

Dr. Xiaolin Wu⁵


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 September 2018 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
QOQiang Ou
Qiang Ou
YWYuanyuan Weng
Yuanyuan Weng
SWSiwei Wang
Siwei Wang
YZYajuan Zhao
Yajuan Zhao
FZFeng Zhang
Feng Zhang
XWXiaolin Wu⁵
Xiaolin Wu⁵

23 August 2023 in Microbiological Research
Verified
Journal Article
Open access
XLXinyi Li
Xinyi Li
FWFan Wang
Fan Wang
ZGZhenfei Gao
Zhenfei Gao
WHWeijun Huang
Weijun Huang
XZXiaoman Zhang
Xiaoman Zhang
SYShankai Yin
Shankai Yin
Chronic intermittent hypoxia (CIH) triggers subclinical intestinal barrier disruption prior to systemic low-grade inflammation. Increasing evidence suggests therapeutic effects of melatonin on systemic inflammation and gut microbiota remodelling. However, whether and how melatonin alleviates CIH-induced intestinal barrier dysfunction remains unclear. C57BL/6 J mice and Caco-2 cell line were treated. We evaluated gut barrier function spectrophotometrically using fluorescein isothiocyanate (FITC)-labelled dextran. Immunohistochemical and immunofluorescent staining were used to detect morphological changes in the mechanical barrier. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) revealed the expression of tight junctions, signal transducer and activator of transcription 3 (STAT3) levels. 16 S rRNA analysis of the colonic contents microflora. Flow cytometry was used to detect cytokines and Th17 cells with and without melatonin supplementation. We found that CIH could induce colonic mucosal injury, including reduction in the number of goblet cells and decrease the expression of intestinal tight junction proteins. CIH could decrease the abundance of the beneficial genera Clostridium, Akkermansia, and Bacteroides, while increasing the abundance of the pathogenic genera Desulfovibrio and Bifidobacterium. Finally, CIH facilitated Th17 differentiation via the phosphorylation of signal transducer and activator of transcription 3 (STAT3) in vitro and elevated the circulating pro-inflammatory cytokine in vivo. Melatonin supplementation ameliorated CIH-induced intestinal mucosal injury, gut microbiota dysbiosis, enteric Th17 polarization, and systemic low-grade inflammation reactions mentioned-above. Melatonin attenuated CIH-induced intestinal barrier dysfunction by regulating gut flora dysbiosis, mucosal epithelium integrity, and Th17 polarization via STAT3 signalling.

31 July 2013 in BMC Neuroscience
Verified
Journal Article
Open access
PDF file
YCYan Chen
Yan Chen
YNYing-Yin Ni
Ying-Yin Ni
JLJie Liu
Jie Liu
JLJia-Wei Lu
Jia-Wei Lu
FWFang Wang
Fang Wang
ZRZhi-Hua Ren
Zhi-Hua Ren
Background: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces Parkinson’s disease (PD)-like neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) via its oxidized product, 1-methyl-4-phenylpyridinium (MPP+), which is transported by the dopamine (DA) transporter into DA nerve terminals. DA receptor subtype 3 (D3 receptor) participates in neurotransmitter transport, gene regulation in the DA system, physiological accommodation via G protein-coupled superfamily receptors and other physiological processes in the nervous system. This study investigated the possible correlation between D3 receptors and MPTP-induced neurotoxicity. A series of behavioral experiments and histological analyses were conducted in D3 receptor-deficient mice, using an MPTP-induced model of PD.Results: After the fourth MPTP injection, wild-type animals that received 15 mg/kg per day displayed significant neurotoxin-related bradykinesia. D3 receptor-deficient mice displayed attenuated MPTP-induced locomotor activity changes. Consistent with the behavioral observations, further neurohistological assessment showed that MPTP-induced neuronal damage in the SNpc was reduced in D3 receptor-deficient mice.Conclusions: Our study indicates that the D3 receptor might be an essential molecule in MPTP-induced PD and provides a new molecular mechanism for MPTP neurotoxicity.

1 October 2023 in Nature and Science of Sleep
Verified
Journal Article
Open access
PDF file
XLXinyi Li
Xinyi Li
TWTao Wang
Tao Wang
LJLi Jin
Li Jin
ZLZhiqiang Li
Zhiqiang Li
CHCheng Hu
Cheng Hu
XWXiaolin Wu⁵
Xiaolin Wu⁵
Objective: Both obstructive sleep apnea (OSA) and obesity are highly prevalent worldwide, and are intrinsically linked. Previous studies showed that obesity is one of the major risk factors for OSA, but the causality of the relationship is still unclear. The study was to investigate the causal relationships of overall obesity and abdominal obesity with OSA and its quantitative traits. Methods: In this case-control study, a total of 7134 participants, including 4335 moderate-to-severe OSA diagnosed by standard polysomnography and 2799 community-based controls were enrolled. Anthropometric and biochemical data were collected. Mendelian randomization (MR) analyses were performed using the genetic risk score, based on 29 body mass index (BMI)- and 11 waist-hip-ratio (WHR)-associated single nucleotide polymorphisms as instrumental variables. The causal associations of these genetic scores with OSA and its quantitative phenotypes were analyzed. Results: Obesity was strongly correlated with OSA in observational analysis (β= 0.055, P = 3.7 × 10− 5). In MR analysis, each increase by one standard deviation in BMI was associated with increased OSA risk [odds ratio (OR): 2.21, 95% confidence interval (CI): 1.62– 3.02, P = 5.57 × 10− 7] and with 2.72-, 4.68-, and 3.25-fold increases in AHI, ODI, and MAI, respectively (all P < 0.05) in men. However, no causal associations were found between WHR and OSA risk or OSA quantitative traits in men and women. Conclusion: Compared to abdominal obesity, overall obesity showed a causal relationship with OSA and its quantitative traits, especially in men.

5 February 2019 in Molecular Medicine Reports
Verified
Journal Article
Open access
PDF file
QOQiang Ou
Qiang Ou
YZYajuan Zhao
Yajuan Zhao
JZJianhua Zhou
Jianhua Zhou
XWXiaolin Wu⁵
Xiaolin Wu⁵
Recent studies have revealed that circular RNAs (circRNAs) are involved in the development of various liver diseases. However, the regulatory role of circRNAs in nonalcoholic steatohepatitis (NASH) has not been fully elucidated. In the present study, the circRNA profiles in a NASH mouse model were investigated, and their functions in NASH were predicted using bioinformatics analysis, with the aim of providing novel clues for delineating the mechanisms of action. A NASH mouse model was established by feeding mice with a methionine and choline‑deficient diet. The liver circRNA profile was screened using a circRNA microarray, and the differentially expressed circRNAs were verified by reverse transcription‑quantitative polymerase chain reaction. Subsequently, circRNA‑microRNA (miRNA) interactions were predicted. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to annotate the biological functions of host linear transcripts of circRNA. A total of 450 circRNAs were revealed to be dysregulated, with 298 circRNAs upregulated and 152 circRNAs downregulated in the NASH model mice. circRNA_29981 was identified as a significantly differentially expressed circRNA. The results from the circRNA‑miRNA pathway interaction analysis revealed that circRNA_29981 was a potential regulator of hepatic stellate cell activation. The host linear transcripts were also analyzed, and the top 10 enriched GO entries and KEGG pathways were annotated. These findings suggested that circRNAs may be important regulators of NASH. Taken together, the results of the present study demonstrated that the circRNA profile in NASH may provide potential candidates for future studies aimed at elucidating the pathogenic mechanism(s) involved in the disease.

12 August 2015 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Open access
PDF file
XFX. Fan
X. Fan
XCX. Chen
X. Chen
CWC. Wang
C. Wang
JDJ. Dai
J. Dai
YLY. Lu
Y. Lu
XWXiaolin Wu⁵
Xiaolin Wu⁵
Background Epidemiologic studies recently revealed that using drospirenone (DRSP)‐containing contraceptives is associated with an increased risk of thrombosis in women. However, the underlying causality is unclear. Objective To study the effects of DRSP on coagulation in vitro and the probable mechanisms involved. Methods First, the effects of DRSP on the activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and fibrinogen (FIB) were measured. Then, the effects of DRSP on platelet activation were investigated in response to low levels of collagen, adenosine 5′‐diphosphate (ADP), thrombin, U46619, adrenaline and botrocetin/von Willebrand factor (VWF). Results DRSP has no direct effect on APTT, PT, TT, FIB and platelet aggregation induced by low levels of collagen, ADP, thrombin, U46619 or adrenaline. However, DRSP enhances botrocetin/VWF‐induced platelet aggregation and VWF receptor glycoprotein Ib‐IX‐V (GPIb‐IX‐V)‐mediated signaling. This enhancement can be blocked by the progesterone receptor membrane component 1 (PGRMC1) inhibitor AG205, or by the ADP scavenger apyrase and the cyclooxygenase inhibitor indomethacin. Conclusions Although DRSP did not directly induce platelet activation, it obviously facilitated VWF receptor GPIb‐IX‐V‐mediated platelet activation. The potential DRSP‐binding protein PGRMC1 may play a role in this process. Our study also suggested that the inhibition of thromboxane A2 production and the activation of ADP receptors might prevent the side‐effects of DRSP.